As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at online marketplace stocks, starting with Shutterstock (NYSE:SSTK).
Healthcare Providers & Services Stocks Q4 In Review: The Ensign Group (NASDAQ:ENSG) Vs Peers
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including The Ensign Group (NASDAQ:ENSG) and its peers.
HR Software Stocks Q4 Recap: Benchmarking Paychex (NASDAQ:PAYX)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Paychex (NASDAQ:PAYX) and the rest of the HR software stocks fared in Q4.
Winners And Losers Of Q4: Verra Mobility (NASDAQ:VRRM) Vs The Rest Of The Electrical Systems Stocks
Let’s dig into the relative performance of Verra Mobility (NASDAQ:VRRM) and its peers as we unravel the now-completed Q4 electrical systems earnings season.
3 Reasons to Avoid BOOT and 1 Stock to Buy Instead
Boot Barn has gotten torched over the last six months - since September 2024, its stock price has dropped 33.7% to $102.45 per share. This might have investors contemplating their next move.
Q4 Rundown: Howmet (NYSE:HWM) Vs Other Aerospace Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Howmet (NYSE:HWM) and the rest of the aerospace stocks fared in Q4.
3 Reasons GNK is Risky and 1 Stock to Buy Instead
Over the last six months, Genco’s shares have sunk to $14.42, producing a disappointing 16.4% loss while the S&P 500 was flat. This might have investors contemplating their next move.
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH)
Looking back on outpatient & specialty care stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including U.S. Physical Therapy (NYSE:USPH) and its peers.
Rheinmetall overtakes Volkswagen's market value as defence rally continues
FRANKFURT (Reuters) -Rheinmetall, Europe's biggest ammunition maker, has overtaken the continent's top carmaker Volkswagen in terms of market value, in the latest sign of soaring investor demand for defence stocks. Defence stocks across Europe have sky-rocketed in recent weeks, driven by the continent's efforts to ramp up military spending in response to U.S. pressure and policy shifts.
'Magnificent 7' stocks aren't the only high-flying tech names getting hit hardest in this sell-off
The "Magnificent Seven" stocks have dominated market conversation this month. They're not the only names getting hit hard during this market sell-off.